Stockreport

A Look Back at Drug Development Inputs & Services Stocks' Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack [Yahoo! Finance]

Repligen Corporation  (RGEN) 
Last repligen corporation earnings: 2/20 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: repligen.com/investors
PDF Today we are looking at Repligen (NASDAQ:RGEN) and the best and worst performers in the drug development inputs & services industry. Companies specializing in drug dev [Read more]